328 related articles for article (PubMed ID: 17381798)
1. Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
Sundram UN; Natkunam Y
J Cutan Pathol; 2007 Apr; 34(4):289-95. PubMed ID: 17381798
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous mastocytosis with atypical mast cells and giant cytoplasmic granules.
Lachapelle J; Moroz B; Nguyen VH
J Cutan Pathol; 2012 Aug; 39(8):773-6. PubMed ID: 22725660
[TBL] [Abstract][Full Text] [Related]
4. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
Li WV; Kapadia SB; Sonmez-Alpan E; Swerdlow SH
Mod Pathol; 1996 Oct; 9(10):982-8. PubMed ID: 8902835
[TBL] [Abstract][Full Text] [Related]
6. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
[TBL] [Abstract][Full Text] [Related]
7. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation.
Sperr WR; Drach J; Hauswirth AW; Ackermann J; Mitterbauer M; Mitterbauer G; Foedinger M; Fonatsch C; Simonitsch-Klupp I; Kalhs P; Valent P
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6787-92. PubMed ID: 16203765
[TBL] [Abstract][Full Text] [Related]
8. A case of cutaneous mastocytosis in a child with prominent Langerhans cell infiltration.
Mitsuya J; Hara H; Fukuda N; Terui T
Pediatr Dermatol; 2011; 28(4):412-5. PubMed ID: 20738800
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Hahn HP; Hornick JL
Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
[TBL] [Abstract][Full Text] [Related]
10. Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis.
Ribatti D; Nico B; Finato N; Crivellato E; Beltrami CA
Cancer Lett; 2009 Jul; 279(2):209-12. PubMed ID: 19250736
[TBL] [Abstract][Full Text] [Related]
11. Myeloid leukemia cutis: a histologic and immunohistochemical review.
Cibull TL; Thomas AB; O'Malley DP; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):180-5. PubMed ID: 18190442
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients.
Won D; Chi HS; Shim H; Jang S; Park CJ; Lee JH
Leuk Res; 2013 Aug; 37(8):883-8. PubMed ID: 23683787
[TBL] [Abstract][Full Text] [Related]
13. Mastocytosis and related disorders.
Chiu A; Orazi A
Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
[TBL] [Abstract][Full Text] [Related]
14. On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.
Valent P; Ghannadan M; Akin C; Krauth MT; Selzer E; Mayerhofer M; Sperr WR; Arock M; Samorapoompichit P; Horny HP; Metcalfe DD
Eur J Clin Invest; 2004 Aug; 34 Suppl 2():41-52. PubMed ID: 15291805
[TBL] [Abstract][Full Text] [Related]
15. CD163 expression in leukemia cutis.
Harms PW; Bandarchi B; Ma L
J Cutan Pathol; 2010 Sep; 37(9):953-7. PubMed ID: 20175823
[TBL] [Abstract][Full Text] [Related]
16. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
[TBL] [Abstract][Full Text] [Related]
17. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells.
Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP
Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475
[TBL] [Abstract][Full Text] [Related]
18. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
[TBL] [Abstract][Full Text] [Related]
19. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
Baghestanian M; Bankl Hc; Sillaber C; Beil WJ; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
Leukemia; 1996 Jan; 10(1):159-66. PubMed ID: 8558922
[TBL] [Abstract][Full Text] [Related]
20. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]